TR200102236T2 - Kolesterol-düşürme amilinin kullanımı. - Google Patents
Kolesterol-düşürme amilinin kullanımı.Info
- Publication number
- TR200102236T2 TR200102236T2 TR2001/02236T TR200102236T TR200102236T2 TR 200102236 T2 TR200102236 T2 TR 200102236T2 TR 2001/02236 T TR2001/02236 T TR 2001/02236T TR 200102236 T TR200102236 T TR 200102236T TR 200102236 T2 TR200102236 T2 TR 200102236T2
- Authority
- TR
- Turkey
- Prior art keywords
- cholesterol
- lowering agent
- dosages
- bulus
- dihydroxyhept
- Prior art date
Links
- 239000003529 anticholesteremic agent Substances 0.000 title 1
- 229940127226 anticholesterol agent Drugs 0.000 title 1
- 150000002632 lipids Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
Bulus, (E)-7-[4, (4-flüorofenil)) -6-izopropil-2-[metil (metilsülfonil)amino]pirimidin-5-il]-(3R, 5S)- 3,5-dihidroksihept-6-enoik asidin ya da bunun eczacilik ile ilgili olarak kabul edilebilir bir tuzunun belirli agizdan alinan dozajlarinin ya da dozaj erimlerinin bunun ihtiyaci içinde olan bir hastada faydali bir sekilde lipit seviyelerini ya da lipit oranlarini degistirmek üzere kullanimina oldugu kadar, bu türden dozajlari ihtiva eden agiz yolu ile ilaç olarak verilmeye yönelik olarak adapte edilmis olan sözü edilen bilesigin ya da tuzlarin eczacilik ile ilgili terkiplerine, ve bunlarin hazirlanmasina iliskin metodlara da iliskindir.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9902590.0A GB9902590D0 (en) | 1999-02-06 | 1999-02-06 | Use of cholesterol-lowering agent |
| GBGB9921062.7A GB9921062D0 (en) | 1999-09-08 | 1999-09-08 | Use of cholestrol-lowering agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200102236T2 true TR200102236T2 (tr) | 2001-12-21 |
Family
ID=26315084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/02236T TR200102236T2 (tr) | 1999-02-06 | 2000-02-01 | Kolesterol-düşürme amilinin kullanımı. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1150679A1 (tr) |
| JP (2) | JP2002536333A (tr) |
| KR (1) | KR100699287B1 (tr) |
| CN (1) | CN1347320A (tr) |
| AR (1) | AR022462A1 (tr) |
| AU (1) | AU769897B2 (tr) |
| BR (1) | BR0007991A (tr) |
| CA (1) | CA2358641A1 (tr) |
| CZ (1) | CZ20012631A3 (tr) |
| EE (1) | EE04659B1 (tr) |
| HK (1) | HK1040924A1 (tr) |
| HU (1) | HUP0105019A3 (tr) |
| ID (1) | ID30131A (tr) |
| IL (1) | IL144662A0 (tr) |
| IS (1) | IS5996A (tr) |
| MY (1) | MY136382A (tr) |
| NO (1) | NO319827B1 (tr) |
| NZ (1) | NZ512681A (tr) |
| PL (1) | PL349137A1 (tr) |
| SK (1) | SK11112001A3 (tr) |
| TR (1) | TR200102236T2 (tr) |
| WO (1) | WO2000045819A1 (tr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
| SE0103509D0 (sv) * | 2001-10-19 | 2001-10-19 | Astrazeneca Ab | Rosuvastatin in pre demented states |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| WO2007142581A1 (en) * | 2006-06-07 | 2007-12-13 | Astrazeneca Ab | Combination product for the treatment or prevention of dyslipidaemia |
| US8293721B2 (en) | 2007-06-20 | 2012-10-23 | Merck Sharpe & Dohme Corp. | CETP inhibitors derived from benzoxazole arylamides |
| AU2008266954A1 (en) | 2007-06-20 | 2008-12-24 | Merck Sharp & Dohme Corp. | CETP inhibitors derived from benzoxazole arylamides |
| CA2689523A1 (en) * | 2007-06-20 | 2008-12-24 | Merck Sharp & Dohme Corp. | Cetp inhibitors derived from benzoxazole arylamides |
| EP2216095A1 (en) * | 2009-01-27 | 2010-08-11 | Koninklijke Philips Electronics N.V. | Microfluidic device for full blood count |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260446A (en) * | 1989-12-22 | 1993-11-09 | Basf Aktiengesellschaft | Aminothiazoles |
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
-
2000
- 2000-01-31 AR ARP000100408A patent/AR022462A1/es unknown
- 2000-02-01 HU HU0105019A patent/HUP0105019A3/hu unknown
- 2000-02-01 CN CN00803519A patent/CN1347320A/zh active Pending
- 2000-02-01 BR BR0007991-0A patent/BR0007991A/pt not_active Application Discontinuation
- 2000-02-01 HK HK02102713.0A patent/HK1040924A1/zh unknown
- 2000-02-01 KR KR1020017009822A patent/KR100699287B1/ko not_active Ceased
- 2000-02-01 SK SK1111-2001A patent/SK11112001A3/sk not_active Application Discontinuation
- 2000-02-01 NZ NZ512681A patent/NZ512681A/en not_active IP Right Cessation
- 2000-02-01 WO PCT/GB2000/000285 patent/WO2000045819A1/en not_active Ceased
- 2000-02-01 EE EEP200100404A patent/EE04659B1/xx not_active IP Right Cessation
- 2000-02-01 IL IL14466200A patent/IL144662A0/xx unknown
- 2000-02-01 PL PL00349137A patent/PL349137A1/xx not_active Application Discontinuation
- 2000-02-01 CA CA002358641A patent/CA2358641A1/en not_active Abandoned
- 2000-02-01 CZ CZ20012631A patent/CZ20012631A3/cs unknown
- 2000-02-01 JP JP2000596939A patent/JP2002536333A/ja not_active Withdrawn
- 2000-02-01 AU AU23051/00A patent/AU769897B2/en not_active Revoked
- 2000-02-01 EP EP00901748A patent/EP1150679A1/en not_active Withdrawn
- 2000-02-01 ID IDW00200101666A patent/ID30131A/id unknown
- 2000-02-01 TR TR2001/02236T patent/TR200102236T2/tr unknown
- 2000-02-04 MY MYPI20000415A patent/MY136382A/en unknown
-
2001
- 2001-07-10 IS IS5996A patent/IS5996A/is unknown
- 2001-08-03 NO NO20013810A patent/NO319827B1/no active IP Right Review Request
-
2011
- 2011-02-22 JP JP2011035406A patent/JP2011137023A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2305100A (en) | 2000-08-25 |
| IS5996A (is) | 2001-07-10 |
| CA2358641A1 (en) | 2000-08-10 |
| BR0007991A (pt) | 2001-11-06 |
| AR022462A1 (es) | 2002-09-04 |
| NZ512681A (en) | 2003-12-19 |
| IL144662A0 (en) | 2002-05-23 |
| HUP0105019A2 (hu) | 2002-05-29 |
| NO20013810L (no) | 2001-10-03 |
| HUP0105019A3 (en) | 2003-02-28 |
| PL349137A1 (en) | 2002-07-01 |
| NO319827B1 (no) | 2005-09-19 |
| EE04659B1 (et) | 2006-08-15 |
| AU769897B2 (en) | 2004-02-05 |
| JP2002536333A (ja) | 2002-10-29 |
| HK1040924A1 (zh) | 2002-06-28 |
| ID30131A (id) | 2001-11-08 |
| CZ20012631A3 (cs) | 2001-10-17 |
| EP1150679A1 (en) | 2001-11-07 |
| KR20010089631A (ko) | 2001-10-06 |
| EE200100404A (et) | 2002-10-15 |
| MY136382A (en) | 2008-09-30 |
| WO2000045819A1 (en) | 2000-08-10 |
| NO20013810D0 (no) | 2001-08-03 |
| JP2011137023A (ja) | 2011-07-14 |
| CN1347320A (zh) | 2002-05-01 |
| KR100699287B1 (ko) | 2007-03-26 |
| SK11112001A3 (sk) | 2002-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2407532C9 (ru) | Комбинации, предназначенные для лечения заболеваний, включающих пролиферацию клеток | |
| ES2641168T3 (es) | Combinaciones que comprenden metotrexato e inhibidores de la DHODH | |
| CR10114A (es) | Composiciones farmacéuticas que comprenden inhibidoras de la hmg coa reductasa (divisional del exp. 6687) | |
| DE69812949D1 (de) | Hydroxamsäurederivat und antitumormittel enthaltende pharmazeutische zusammensetzung mit verbesserter antitumor-aktivität und/oder verringerten nebenwirkungen | |
| CY1109756T1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν κρυσταλλικα αλατα 7-[4-(4-φθοροφαινυλ)-6-ισοπροπυλ-2- [μεθυλ(μεθυλσουλφονυλ)αμινο] πυριμιδιν-5-υλ]-(3r,5s)-3,5-διυδροξυεπτ-6-ενοϊκου οξεος | |
| BR0113331A (pt) | Derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica | |
| ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
| TR200001399T2 (tr) | Siklik amin türevleri ve ilaç olarak kullanımları. | |
| TR200103613T2 (tr) | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. | |
| HUP0301380A2 (hu) | Roszuvasztatin (ZD-4522) felhasználása heterozigóta örökletes hiperkoleszterolémia kezelésére alkalmas gyógyszerkészítmény előállítására | |
| JP2006508953A5 (tr) | ||
| JPH11193282A5 (tr) | ||
| ATE359777T1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
| NO20034863L (no) | Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser | |
| TR199900336T2 (tr) | EAA antagonistleri olarak tetrahidrokinolin türevleri. | |
| BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
| TR200103153T2 (tr) | Yeni bileşimler | |
| SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
| TR200102236T2 (tr) | Kolesterol-düşürme amilinin kullanımı. | |
| CA2302568A1 (en) | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
| RU2334517C2 (ru) | Средство, потенцирующее противоопухолевый эффект, и противоопухолевое средство | |
| ATE13488T1 (de) | Gallium-chlorid, ein neues antikrebsmittel. | |
| JP2002536333A5 (tr) | ||
| BR0007513A (pt) | Fosfatidilinositóis sulfatados, sua preparação euso |